Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 712 | 2018 |
Comprehensive genomic characterization of upper tract urothelial carcinoma TJ Moss, Y Qi, L Xi, B Peng, TB Kim, NE Ezzedine, ME Mosqueda, ... European urology 72 (4), 641-649, 2017 | 198 | 2017 |
Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy Y Fang, DJ McGrail, C Sun, M Labrie, X Chen, D Zhang, Z Ju, CP Vellano, ... Cancer cell 35 (6), 851-867. e7, 2019 | 180 | 2019 |
Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape Z Wang, TB Kim, B Peng, J Karam, C Creighton, A Joon, F Kawakami, ... Clinical Cancer Research 23 (21), 6686-6696, 2017 | 84 | 2017 |
Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal V Morris, X Rao, C Pickering, WC Foo, A Rashid, K Eterovic, T Kim, ... Molecular Cancer Research 15 (11), 1542-1550, 2017 | 69 | 2017 |
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer F Meric-Bernstam, X Zheng, M Shariati, S Damodaran, C Wathoo, ... JCO precision oncology 2, 1-15, 2018 | 64 | 2018 |
Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations MT Tetzlaff, JL Curry, J Ning, O Sagiv, TL Kandl, B Peng, D Bell, ... Clinical Cancer Research 25 (4), 1280-1290, 2019 | 47 | 2019 |
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma R Ruiz-Cordero, P Rao, L Li, Y Qi, D Atherton, B Peng, RR Singh, TB Kim, ... Modern Pathology 32 (11), 1698-1707, 2019 | 46 | 2019 |
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, ... JCO Precision Oncology 6, e2100267, 2022 | 45 | 2022 |
Phase Ib dose expansion and translational analyses of olaparib in combination with capivasertib in recurrent endometrial, triple-negative breast, and ovarian cancer SN Westin, M Labrie, JK Litton, A Blucher, Y Fang, CP Vellano, ... Clinical Cancer Research 27 (23), 6354-6365, 2021 | 34 | 2021 |
Use of targeted next-generation sequencing to identify activating hot spot mutations in cherry angiomas N Klebanov, WM Lin, M Artomov, M Shaughnessy, CN Njauw, R Bloom, ... JAMA dermatology 155 (2), 211-215, 2019 | 29 | 2019 |
Genomic, transcriptomic, and proteomic profiling of metastatic breast cancer A Akcakanat, X Zheng, CX Cruz Pico, TB Kim, K Chen, A Korkut, A Sahin, ... Clinical Cancer Research 27 (11), 3243-3252, 2021 | 21 | 2021 |
Cancer driver mutation prediction through Bayesian integration of multi-omic data Z Wang, KS Ng, T Chen, TB Kim, F Wang, K Shaw, KL Scott, ... PLoS one 13 (5), e0196939, 2018 | 20 | 2018 |
T2R bitter taste receptors regulate apoptosis and may be associated with survival in head and neck squamous cell carcinoma RM Carey, DB McMahon, ZA Miller, TB Kim, K Rajasekaran, I Gopallawa, ... Molecular oncology 16 (7), 1474-1492, 2022 | 17 | 2022 |
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries OL Veeranki, Z Tong, A Mejia, A Verma, R Katkhuda, R Bassett, TB Kim, ... Disease models & mechanisms 12 (12), dmm041004, 2019 | 17 | 2019 |
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options M Labrie, TB Kim, Z Ju, S Lee, W Zhao, Y Fang, Y Lu, K Chen, P Ramirez, ... Oncotarget 10 (37), 3533, 2019 | 17 | 2019 |
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis MK Nowakowska, T Kim, MT Thompson, KL Bolton, A Deswal, SH Lin, ... American journal of hematology 97 (4), 411-420, 2022 | 14 | 2022 |
Existence of a unique solution to a nonlinear moving-boundary problem of mixed type arising in modeling blood flow S Čanić, A Mikelić, TB Kim, G Guidoboni Nonlinear Conservation Laws and Applications, 235-256, 2011 | 14 | 2011 |
Incorporating ENCODE information into association analysis of whole genome sequencing data T Kim, P Wei BMC proceedings 10, 257-261, 2016 | 11 | 2016 |
Impact of sweet, umami, and bitter taste receptor (TAS1R and TAS2R) genomic and expression alterations in solid tumors on survival RM Carey, TB Kim, NA Cohen, RJ Lee, KT Nead Scientific reports 12 (1), 8937, 2022 | 10 | 2022 |